PharmaEngine, Inc. (TPEX:4162)
Taiwan · Delayed Price · Currency is TWD 57.00
+0.10 (0.18%)
Mar 24, 2026, 1:30 PM CST
PharmaEngine Market Cap
PharmaEngine has a market cap or net worth of 8.18 billion as of March 23, 2026. Its market cap has decreased by -50.52% in one year.
Market Cap
8.18B
Enterprise Value
3.50B
Revenue
911.42M
Ranking
n/a
PE Ratio
21.15
Stock Price
57.00
Market Cap Chart
Since September 1, 2011, PharmaEngine's market cap has increased from 5.38B to 8.18B, an increase of 51.99%. That is a compound annual growth rate of 2.92%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 23, 2026 | 8.18B | -19.18% |
| Dec 31, 2025 | 10.11B | -22.04% |
| Dec 31, 2024 | 12.97B | -14.41% |
| Dec 29, 2023 | 15.16B | -15.60% |
| Dec 30, 2022 | 17.96B | 75.96% |
| Dec 30, 2021 | 10.21B | 21.08% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Tanvex BioPharma | 11.02B |
| TCM Biotech International | 10.54B |
| Gongwin Biopharm Holdings | 8.47B |
| TaiGen Biopharmaceuticals Holdings | 8.04B |
| Adimmune | 7.73B |
| Acepodia | 6.96B |
| Mycenax Biotech | 6.42B |
| Savior Lifetec | 6.40B |